| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |